Clinical Trial Update: Short-Term Effect Of Ceriter Stride One (CSO) on FOG and Falling in pwP [NA]

View source ↗

Summary

A completed clinical trial evaluated the short-term effect of Ceriter Stride One (CSO) on freezing of gait and falls in people with Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gait Disorders
• Parkinson Disease

Drugs mentioned

• Ceriter Stride One

Snippet

Sponsor: University Ghent | Conditions: Gait, Festinating, Parkinson Disease | NA | Status: COMPLETED